Journal for ImmunoTherapy of Cancer (JITC) Editor-in-Chief Dr. Michael T. Lotze will be at the 2026 WIC-APAC meeting in Taipei, Taiwan presenting on the science of tumor-infiltrating lymphocytes on March 28. He’s ready to “talk JITC” for anyone interested in learning more about the journal and getting your work published with us.